Senores Pharmaceuticals Limited (BOM:544319)
1,042.95
-5.85 (-0.56%)
At close: Jun 4, 2026
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 47.65 billion as of June 5, 2026. Its market cap has increased by 108.57% in one year.
Market Cap
47.65B
Enterprise Value
49.79B
Revenue
6.33B
Ranking
n/a
PE Ratio
40.94
Stock Price
1,042.95
Market Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 47.65B, an increase of 85.75%. That is a compound annual growth rate of 54.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 47.65B | 25.85% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 104.16B |
| Procter & Gamble Health | 101.47B |
| Sanofi India | 73.25B |
| FDC Limited | 64.99B |
| Bliss GVS Pharma | 46.48B |
| Gufic Biosciences | 36.40B |
| Novartis India | 32.74B |
| Unichem Laboratories | 26.24B |